| 
          
          
          Provisions Of DPCO, 2013 Applicable To Notified Medical Devices: NPPA 
          The National Pharmaceutical Pricing 
          Authority (NPPA) has clarified that orthopaedic implants along with 
          other medical devices will be treated as drugs, hence provisions of 
          DPCO, 2013 are applicable to notified medical devices. 
          Refuting the contention of the medical 
          devices manufacturers, especially the manufacturers of orthopaedic 
          implants, that the provisions of DPCO 2013 are not applicable to 
          medical devices, the NPPA said, “Para 20 of DPCO, 2013 provides for 
          monitoring of non-scheduled formulations. Orthopaedic implants along 
          with other medical devices are notified as ‘drug’ under Drugs & 
          Cosmetics Act & Rules thereunder. Therefore your contention that the 
          provisions of DPCO, 2013 are not applicable to medical devices is 
          totally incorrect... 
          
          Gujarat FDCA To Meet Commerce Ministry To Seek Release Of Funds For 
          Biocompatibility & Medical Device Testing Lab 
          Gujarat Food & Drugs Control 
          Administration (FDCA) is expected to meet commerce ministry to speed 
          up the release of funds for setting up of the country’s first 
          biocompatibility and medical device testing lab. The state drug 
          regulator had earlier this year drafted a proposal to the Centre to 
          sanction a budgetary allocation of Rs.15 crore for the same... 
          
          U.S.-India Business Council Concludes Successful Medical Device Trade 
          Mission To India 
          The U.S.-India Business Council (USIBC) 
          concluded its Medical Device Trade Mission to New Delhi and 
          Gandhinagar. The delegation expressed its commitment to addressing 
          India’s most pressing public health challenges, and called for further 
          dialogue with the government on issues related to ease of doing 
          business, disease management, and the implementation of training 
          programs for medical device regulators... |